Laddar...
Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications
Lopinavir-ritonavir combination is being used for the treatment of SARS-CoV-2 infection. A low dose of ritonavir is added to other protease inhibitors to take advantage of potent inhibition of cytochrome (CYP) P450 3A4, thereby significantly increasing the plasma concentration of coadministered lopi...
Sparad:
| I publikationen: | Cardiovasc Drugs Ther |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer US
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7486594/ https://ncbi.nlm.nih.gov/pubmed/32918656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-020-07070-1 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|